ForthRight Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
ForthRight Wealth Management's BMY Position: Q1 2021 in Review
ForthRight Wealth Management sold out of Bristol-Myers Squibb (BMY) in Q1 2021, closing a stake of 85 shares — an estimated $5K sold.
ForthRight Wealth Management first reported a position in BMY in Q4 2020 and held it in 1 quarter. The position peaked at $5K in Q4 2020. 2,368 funds tracked by Wall St. Rank hold BMY as of Q1 2021.
- ForthRight Wealth Management reported no remaining Bristol-Myers Squibb position as of Q1 2021 after selling out during the quarter.
- ForthRight Wealth Management sold 85 Bristol-Myers Squibb shares in Q1 2021, an estimated $5K.
- ForthRight Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2020 and held it in 1 quarter.
- ForthRight Wealth Management's Bristol-Myers Squibb position peaked at $5K in Q4 2020.
- 2,368 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2021.
Based on ForthRight Wealth Management's 13F filing for Q1 2021, filed 26 Apr 2021.